Aktionsplan Centogene N.V.
Erweiterter Zeitplan
Einfaches Diagramm
Über das Unternehmen
Centogene N.V., together with its subsidiaries, engages in the research and development of products for human genetics in Europe, the Middle East, North America, Latin America, and the Asia Pacific. It provides data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It operates through two segments: Pharmaceutical and Diagnostics. The company provides target and drug screening, clinical development, market access and expansion, as well as CENTOGENE Biodatabank licenses and insight report services. weitere details| EBITDA | -0.0045 |
|---|---|
| EV/EBITDA | -2.32 |
| IPO date | 2019-11-07 |
| ISIN | NL0014040206 |
| Industry | Health Care Providers & Services |
| P/BV | 2.69 |
| P/S | 3.25 |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | eur |
| Выручка | 0.0405 |
| Сайт | https://www.centogene.com |
| Цена ао | 0.2238 |
| Число акций ао | 0.02681 млрд |
| Preisänderung pro Tag: | 0% (0.1211) |
|---|---|
| Preisänderung pro Woche: | -9.9% (0.1344) |
| Preisänderung pro Monat: | +34.56% (0.09) |
| Preisänderung über 3 Monate: | -39.45% (0.2) |
| Preisänderung über sechs Monate: | -70.32% (0.408) |
| Preisänderung pro Jahr: | -89.91% (1.2) |
| Preisänderung über 3 Jahre: | -97.66% (5.17) |
| Preisänderung über 5 Jahre: | -99.07% (13.05) |
| Preisänderung über 10 Jahre: | 0% (0.1211) |
| Preisänderung seit Jahresbeginn: | 0% (0.1211) |
|
|
Unterschätzung
|
Effizienz
|
|||||||||||||||||||||||||||||||||||||
Dividenden
|
Pflicht
|
Wachstumsimpuls
|
|||||||||||||||||||||||||||||||||||||
| Institutionen | Volumen | Aktie, % |
|---|---|---|
| Platinum Investment Management Ltd | 2377150 | 8.61 |
| Wells Fargo & Company | 206389 | 0.75 |
| Acadian Asset Management. LLC | 24703 | 0.09 |
| Blackrock Inc. | 21578 | 0.08 |
| Millennium Management LLC | 19731 | 0.07 |
| Morgan Stanley | 18231 | 0.07 |
| Stifel Financial Corporation | 16450 | 0.06 |
| Barclays PLC | 15348 | 0.06 |
| Geode Capital Management, LLC | 11156 | 0.04 |
| Meeder Asset Management, Inc. | 138 | 0 |
| Aufsicht | Berufsbezeichnung | Zahlung | Geburtsjahr |
|---|---|---|---|
| Ms. Kim Stratton | CEO & Member of Management Board | 932.62k | 1962 (63 Jahr) |
| Mr. Jose Miguel Coego Rios | CFO, Legal & IT and Member of Management Board | 323.87k | 1974 (51 Jahr) |
| Dr. Peter Bauer M.D. | Interim MD, Chief Medical & Genomic Officer and Member of Management Board | 186.31k | 1970 (55 Jahre) |
| Dr. Andrin Oswald M.D., Ph.D. | Advisor | 943.45k | 1972 (53 Jahr) |
| Mr. Ian Rentsch | Chief Commercial Officer & GM of Pharma | N/A | 1976 (49 Jahre) |
Adresse: Germany, Rostock, Am Strande 7 - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.centogene.com
Webseite: https://www.centogene.com
